Safety of Oral Ibandronate in the Treatment of Bone Metastases from Breast Cancer: Long-Term Follow-Up Experience

By McLachlan Sue-Anne  

Clinical Drug Investigation, Vol. 26, Iss. 1, 2006-01 ,pp. : 43-48

Adis International

Access to resources Recommend Favorite

Cost-effectiveness of Oral Clodronate Compared with Oral Ibandronate, Intravenous Zoledronate or Intravenous Pamidronate in Breast Cancer Patients

By Paterson A   McCloskey E   Redzepovic J   Ott I   Gust R  

The Journal of International Medical Research, Vol. 36, Iss. 3, 2008-05 ,pp. : 400-413

Field House Publishing

Access to resources Recommend Favorite

Clodronate: A Review of its Use in Breast Cancer

By Hurst M.   Noble S.  

Drugs & Aging, Vol. 15, Iss. 2, 1999-08 ,pp. : 143-167

Adis International

Access to resources Recommend Favorite

Long-term female hormone use a risk factor for breast cancer?

By  

Reactions Weekly, Vol. 1, Iss. 1102, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Clodronate: A Review of its Use in the Prevention of Bone Metastases and the Management of Skeletal Complications Associated with Bone Metastases in Patients with Breast Cancer

By Toni M. Dando   Lynda R. Wiseman  

Drugs & Aging, Vol. 21, Iss. 14, 2004-01 ,pp. : 949-962

Adis International

Access to resources Recommend Favorite